ERK inhibitors

2 abstracts

Abstract
Response to RAF/MEK/ERK inhibitors in patients with RAS altered and wild-type tumors.
Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan, Department of Investigational Cancer Therapeutics,
Abstract
PUF: A potential repressor of oncogenes.
Org: East Carolina University Brody School of Medicine, East Carolina University/Vidant Cancer Center,